These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

726 related articles for article (PubMed ID: 15258855)

  • 21. Postchemotherapy purine excretion in lymphoma patients receiving allopurinol.
    Hande KR; Hixson CV; Chabner BA
    Cancer Res; 1981 Jun; 41(6):2273-9. PubMed ID: 7237428
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of high urinary xanthine excretion with increased amounts of allopurinol and with urate oxidase in a child with Lesch-Nyhan syndrome (author's transl)].
    Beyer P; Bieth R; Charton F; Himy G
    Ann Pediatr (Paris); 1980 Dec; 27(10):661-6. PubMed ID: 7212552
    [No Abstract]   [Full Text] [Related]  

  • 23. [Juvenile gout with decreased activity of hypoxanthine-guanine-phosphoribosyl transferase and pheochromocytoma: partial persistence of tophi despite uric-acid reducing treatment for 12 years (author's transl)].
    Zöllner N; Goebel FD; Ohlschlägel G; Gröbner W
    Dtsch Med Wochenschr; 1978 Jun; 103(25):1044, 1047-9. PubMed ID: 668512
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The pharmacokinetics of injectable allopurinol in newborns with the hypoplastic left heart syndrome.
    McGaurn SP; Davis LE; Krawczeniuk MM; Murphy JD; Jacobs ML; Norwood WI; Clancy RR
    Pediatrics; 1994 Dec; 94(6 Pt 1):820-3. PubMed ID: 7970996
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparative study on the hypouricemic activity and potency in renal xanthine calculus formation of two xanthine oxidase/xanthine dehydrogenase inhibitors: TEI-6720 and allopurinol in rats.
    Horiuchi H; Ota M; Kobayashi M; Kaneko H; Kasahara Y; Nishimura S; Kondo S; Komoriya K
    Res Commun Mol Pathol Pharmacol; 1999; 104(3):307-19. PubMed ID: 10741381
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Erythrocyte purine phosphoribosyltransferase activity in girls with the Lesch-Nyhan syndrome].
    Aleksandrova LA; Shaposhnikov AM
    Vopr Med Khim; 1981; 27(4):488-92. PubMed ID: 7293080
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment of Lesch-Nyhan syndrome].
    De Antonio I; Torres-Jiménez R; Verdú-Pérez A; Prior de Castro C; García-Puig J
    Rev Neurol; 2002 Nov 1-15; 35(9):877-83. PubMed ID: 12436387
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renal xanthine stone in Lesch-Nyhan syndrome treated with allopurinol.
    Ogawa A; Watanabe K; Minejima N
    Urology; 1985 Jul; 26(1):56-8. PubMed ID: 4012980
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma and urinary oxypurines in Lesch-Nyhan patient after allopurinol treatment.
    Roscioni G; Farnetani MA; Pagani R; Pizzichini M; Marinello E; Porcelli B
    Adv Exp Med Biol; 1994; 370():357-61. PubMed ID: 7660928
    [No Abstract]   [Full Text] [Related]  

  • 30. [Urinary lithiasis revealing Lesch-Nyhan syndrome].
    Lepercq G; Poupinet S; Steinschneider R; Weiler C
    Nouv Presse Med; 1973 Jun; 2(23):1571-4. PubMed ID: 4713405
    [No Abstract]   [Full Text] [Related]  

  • 31. An autopsy case of the Lesch-Nyhan syndrome: normal HGPRT activity in liver and xanthine calculi in various tissues.
    Mizuno T; Endoh H; Konishi Y; Miyachi Y; Akoaka I
    Neuropadiatrie; 1976 Aug; 7(3):351-5. PubMed ID: 989165
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urine alkalinization may be enough for the treatment of bilateral renal pelvis stones associated with Lesch-Nyhan syndrome.
    Oh MM; Ham BK; Kang SH; Bae JH; Kim JJ; Yoo KH; Yoon DK; Moon du G
    Urol Res; 2011 Oct; 39(5):417-9. PubMed ID: 21331772
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The diagnosis of HPRT deficiency in the 21st century.
    Torres RJ; Puig JG
    Nucleosides Nucleotides Nucleic Acids; 2008 Jun; 27(6):564-9. PubMed ID: 18600505
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical spectrum of hypoxanthine-guanine phosphoribosyltransferase deficiency: study of 12 cases].
    García Puig J; Mateos FA; Jiménez ML; Arcas J; Miranda ME; Oríz Vázquez J
    Med Clin (Barc); 1994 May; 102(18):681-7. PubMed ID: 8028417
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Xanthine calculi in the Lesch-Nyhan syndrome.
    Brock WA; Golden J; Kaplan GW
    J Urol; 1983 Jul; 130(1):157-9. PubMed ID: 6864903
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypoxanthine-guanine phosphoribosyltransferase: characteristics of the mutant enzyme in erythrocytes from patients with the Lesch-Nyhan syndrome.
    Arnold WJ; Meade JC; Kelley WN
    J Clin Invest; 1972 Jul; 51(7):1805-12. PubMed ID: 4624352
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Report of a patient with Lesch-Nyhan syndrome caused by total deficiency of HGPRT and with normal activity in female family members].
    Ferrández A; Mayayo E; Nyhan WL; Bakay B
    An Esp Pediatr; 1982 Jul; 17(1):60-4. PubMed ID: 7137725
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Lesch-Nyhan syndrome: a family study.
    Pullon DH; Ballantyne GH; Webster D; Becroft DM
    N Z Med J; 1977 Dec; 86(601):518-21. PubMed ID: 272569
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disparate enzyme activity in erythocytes and leukocytes. A variant of hypoxanthine phosphoribosyl-transferase deficiency with an unstable enzyme.
    Dancis J; Yip LC; Cox RP; Piomelli S; Balis ME
    J Clin Invest; 1973 Aug; 52(8):2068-74. PubMed ID: 4352580
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Identification and quantitation of purine derivatives in urinary calculi as markers of abnormal purine metabolism by using high-performance liquid chromatography (HPLC)].
    Safranow K
    Ann Acad Med Stetin; 2000; 46():35-49. PubMed ID: 11712316
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.